Citation Impact
Citing Papers
GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis
2006
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Rosiglitazone (BRL49653), a PPARγ-selective agonist, causes peroxisome proliferator-like liver effects in obese mice
1999
Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kB activity
1996
Tetanus toxin action: Inhibition of neurotransmitter release linked to synaptobrevin proteolysis
1992 StandoutNobel
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
2006 StandoutNature
Activators and target genes of Rel/NF-κB transcription factors
1999 Standout
Induction and activation of tissue transglutaminase during programmed cell death
1987 Standout
Identification of tissue transglutaminase as the autoantigen of celiac disease
1997 Standout
Interaction of tissue transglutaminase with nuclear transport protein importin‐α3
1999
Tissue transglutaminase: a possible role in neurodegenerative diseases
2000
Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment
2007 Standout
An overview of chemical additives present in plastics: Migration, release, fate and environmental impact during their use, disposal and recycling
2017 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Mechanism of Action of the Nongenotoxic Peroxisome Proliferators: Role of the Peroxisome Proliferator-Activated Receptor
1998
Steatohepatitis, Spontaneous Peroxisome Proliferation and Liver Tumors in Mice Lacking Peroxisomal Fatty Acyl-CoA Oxidase
1998
The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is inactive among a sample human population: significance for species differences in response to PPs
1999
Microplastics as contaminants in the marine environment: A review
2011 Standout
Hydrogen peroxide metabolism during peroxisome proliferation by fenofibrate
1995
PPAR: a mediator of peroxisome proliferator action
1995
Cell Surface Localization of Tissue Transglutaminase Is Dependent on a Fibronectin-binding Site in Its N-terminal β-Sandwich Domain
1999
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
1990 StandoutNature
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Transglutaminase Transcription and Antigen Translocation in Experimental Renal Scarring
1999
Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing
2000 Standout
Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression
1991
A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations
2008 StandoutNobel
The importance of the GTP‐binding protein tissue transglutaminase in the regulation of cell cycle progression
1995
Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences
1999
Cytokines in non-genotoxic hepatocarcinogenesis
1999
In vivo and in vitro induction of ‘tissue’ transglutaminase in rat hepatocytes by retinoic acid
1992
Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha)
1998
The Mechanism of Microsomal Azoreduction: Predictions Based on Electronic Aspects of Structure-Activity Relationships
1995
The cornified envelope: a model of cell death in the skin
2005 Standout
Transglutaminases: crosslinking enzymes with pleiotropic functions
2003 Standout
Antimicrobial activity of metals: mechanisms, molecular targets and applications
2013 Standout
Species differences in sequence and activity of the peroxisome proliferator response element (PPRE) within the acyl CoA oxidase gene promoter
1999
Inflammation and cancer: back to Virchow?
2001 Standout
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Spin Trapping: ESR parameters of spin adducts 1474 1528V
1987 Standout
Differential induction and regulation of peroxisomal enzymes: Predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens
1989
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
The hormone resistin links obesity to diabetes
2001 StandoutNature
Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis
1989
Peroxisomes and oxidative stress
2006
Hepatic peroxisome proliferation in rodents and its significance for humans
1993
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Peroxisome Proliferator-Activated Receptor-alpha and the Pleiotropic Responses to Peroxisome Proliferators
1998
Azobenzene photoswitches for biomolecules
2011 Standout
Induction of Cyclooxygenase-2 Expression by Peroxisome Proliferators and Non-tetradecanoylphorbol 12,13-Myristate-type Tumor Promoters in Immortalized Mouse Liver Cells
1997
Searching For the Function of Tissue Transglutaminase: Its Possible Involvement in the Biochemical Pathway of Programmed Cell Death
1988
Metabolism of AZO Dyes: Implication for Detoxication and Activation
1991
The Toxicology of Perfluorooctanoate
2004
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by Ca2+ and nucleotides
1996
Accumulation and fragmentation of plastic debris in global environments
2009 Standout
Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
2003 StandoutNobel
Synaptobrevin/vesicle-associated membrane protein (VAMP) of Aplysia californica: structure and proteolysis by tetanus toxin and botulinal neurotoxins type D and F.
1994 StandoutNobel
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
The Free Radical Theory of Aging Matures
1998 Standout
In vitro and in vivo antitumor activity of novel 3D-organotin supramolecular coordination polymers based on CuCN and pyridine bases
2011
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
Ring D modifications of ellipticine. Part 2. Chlorination of ellipticine via its N-oxide and synthesis and selective acetylation of 5,6,11-trimethyl-5H-benzo[b]carbazole.
1994
Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion.
1992
Water Analysis: Emerging Contaminants and Current Issues
2014 Standout
Limulus hemocyte transglutaminase. cDNA cloning, amino acid sequence, and tissue localization.
1993
Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator.
1989
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Environmental Implications of Hydroxyl Radicals (•OH)
2015 Standout
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
Genotoxicity Studies of Heavy Metals: Lead, Bismuth, Indium, Silver and Antimony
2009
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
1997 Standout
Peroxisome proliterators and cancer: mechanisms and implications
1986
Redox Regulation of Homeostasis and Proteostasis in Peroxisomes
2017
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Tetanus toxin potently stimulates tissue transglutaminase. A possible mechanism of neurotoxicity.
1992
Applications and societal benefits of plastics
2009 Standout
Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?
1998
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.
1996
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. Use of 2-[(2-oxopropyl)thio] imidazolium derivatives as cellular transglutaminase inactivators.
1991
Decreased susceptibility to copper‐induced oxidation of rat‐lipoproteins after fibrate treatment: influence of fatty acid composition
1996
Generation and Detection of Reactive Oxygen Species in Photocatalysis
2017 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Isolation and Synthesis of Biologically Active Carbazole Alkaloids
2002 Standout
Neurotoxins Affecting Neuroexocytosis
2000 Standout
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Works of B.M. Elliott being referenced
Characterisation of the cellular substrates for transglutaminase in normal liver and hepatocellular carcinoma
1990
Expression of the cytosolic and particulate forms of transglutaminase during chemically induced rat liver carcinogenesis
1988
An assessment of the genetic toxicology of antimony trioxide
1998
Immunological similarities between cytosolic and particulate tissue transglutaminase
1990
The existence of an inactive form of transglutaminase within metastasising tumours
1990
Identification of an alginate-based formulation of paraquat to reduce the exposure of the herbicide following oral ingestion
2007
Alternatives to Aroclor 1254-induced S9 in in vitro genotoxicity assays
1992
Activation of transglutaminase at calcium levels consistent with a role for this enzyme as a calcium receptor protein
1985
Alterations in the distribution and activity of transglutaminase during tumour growth and metastasis
1985
Correlation of changes in transglutaminase activity and polyamine content of neoplastic tissue during the metastatic process
1987
Azoreductase activity of Sprague Dawley and Wistar-derived rats towards both carcinogenic and non-carcinogenic analogues of 4-dimethylaminophenylazobenzene (DAB)
1984
Transglutaminase activity, tumour growth and metastasis
1989
Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis
1994
Lack of DNA damage or lipid peroxidation measured in vivo in the rat liver following treatment with peroxisomal proliferators
1987
Norharman and ellipticine: A comparison of their abilities to interact with DNA in vitro
1980
Triethyltin binding to cat haemoglobin. Evidence for two chemically distinct sites and a role for both histidine and cysteine residues
1979
Irreversible depression in the ratio of tetraploid:diploid liver nuclei in rats treated with 3'-methyl-4-diraethylaminoazobenzene (3'M)
1985
Increased hydroxyl radical production in liver peroxisomal fractions from rats treated with peroxisome proliferators
1986